Brainscan S.A.

Computer programming activities

KRS: NIP: REGON:

Overview

Status
Active
Registry date
2022-11-03
Share capital
127,370.00 PLN
Activity description

Brainscan is a company that develops AI-powered diagnostic systems specifically for analyzing human brain CT scans. It has expanded its capabilities to detect 30 key brain pathologies and is working on a multimodal system for automated diagnosis support, which includes features like the analysis of contrast-enhanced CT scans. The company aims for FDA certification and U.S. patent approval by 2025 to enter the American medical market.

Registered address
ul. Prof. Zdzisława Kieturakisa 10, 80-742 Gdańsk, Poland
Email
Social media
Electronic delivery address
AE:PL-68895-73045-GBIFT-24

Financials

Revenue history (in k)

Filing timeliness

Financial statements were filed on time, on average 10 days early. All were audited by a statutory auditor.

  • 202506/07/2026
  • 202407/07/2025
  • 202328/06/2024
  • 202211/07/2023
Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Stock quotes

PLN 7.90
0.00 (0.00%)
7.807.908.007.90Nov 10Nov 17
Open
PLN 7.90
High
PLN 7.90
Low
PLN 7.90
Volume
330
Avg. vol.
58.2
Market cap
PLN 10.18M
P/E ratio
–
EPS
-PLN 3.34
Shares outstanding
1.29M
52-week
PLN 7.45 – 8.00
Dividend yield
–
Dividend
–
Ex dividend date
–
Exchange
NewConnect

Quarterly results

PeriodRevenueEBITNet profit
Q2 2026USD 52.94kUSD -284.98kUSD -292.27k
Q1 2026USD 23.50kUSD -576.18kUSD -579.69k
Q4 2025USD 4.52kUSD -183.32kUSD -191.86k
Q3 2025USD 5.27kUSD -78.60kUSD -79.36k

Statistics

How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2025.

Industry · Computer programming activities3,464 / 11,174
Top 31%
Sector · Information and communication6,162 / 21,342
Top 29%
City · Gdańsk3,098 / 7,502
Top 41%
Voivodeship · Pomorskie8,918 / 20,062
Top 44%
Country · Poland132,058 / 297,069
Top 44%

Results vs industry

Revenue
This companyUSD 411.06kMedianUSD 120.54kAverageUSD 1.77m
Net profit
This companyUSD -768.30kMedianUSD 2.92kAverageUSD 23.81k
Operating costs
This companyUSD 1.15mMedianUSD 112.29kAverageUSD 1.69m
Assets
This companyUSD 636.87kMedianUSD 79.64kAverageUSD 1.14m

Websites

  • brainscan.aiHome – BrainScan.ai
    WordPress 7.1ElementorApache

Public procurement

2 tenders recorded as contractor, with a total value of $105,610.

SubjectAmount
Development of digital services at Samodzielny Publiczny Zespół Opieki Zdrowotnej w Kędzierzynie-Koźlu to accelerate the digital transformation of healthcare
$68,266
Supply of a system to support interpretation of head CT scans (36-month licence)
$37,344

Authorized Representatives

Adam Rusin age 56 – Management Board Member

Manner of representation

In the case of a one-person management board, the member of the management board makes declarations on behalf of the company. In the case of a management board consisting of two or more persons, joint action by two members of the management board or by one member of the management board jointly with a commercial proxy is required to make declarations on behalf of the company.

Supervisory board

Paweł Jerzy Wilski age 41 – Supervisory Board Member
Małgorzata Panek-Kasińska age 50 – Supervisory Board Member
Marek Trojanowicz age 56 – Supervisory Board Member
Mateusz Marmołowski age 42 – Supervisory Board Member
Wojciech Miśnik age 47 – Supervisory Board Member

Beneficial owners

Person

Bank accounts

Registered as a VAT taxpayer on 2017-11-14.

Debt

No entries in the National Debtors Register (KRZ).

MSiG notices

Publication dateEvent
Nov 13, 2024Commercial Companies Code notice

Public aid

20 public aid cases recorded, with a total value of $4,987,268.

PurposeGross amount
De minimis aid (in accordance with Commission Regulation 2023/2831)
$123
De minimis aid (in accordance with Commission Regulation 2023/2831)
$226
De minimis aid (in accordance with Commission Regulation 2023/2831)
$238

European Funds

ProjectEU co-financing
LUNGSCAN – System supporting the assessment of regression/progression of pathological changes visible in follow-up lung computed tomography scans during and after recovery from acute lung inflammation associated with SARS-CoV-2, based on artificial intelligence methods
$1.1M
Preparation of a project proposal for a Eurogrant planned under the EIC Accelerator programme
$71,814
BRAINSCAN – a system for the automated support of medical diagnostics, detection and localisation of potential pathological changes in head imaging examinations.
$751.4K

Competitors

Name
Spinetime sp. z o.o.
Surveily sp. z o.o.
Medmetrix sp. z o.o.
Aiseemo sp. z o.o.
Affexy sp. z o.o.
IQ Med sp. z o.o.
Cosmoeye sp. z o.o.
Diagu sp. z o.o.
Mo2s P.S.A.
Cephio sp. z o.o.

Change history

DateEvent
2025-04-14Share capital increase
2023-07-24Share capital increase
2022-11-03Entered in the register

FAQ

Last updated: 2026-07-09